Clinical Trial Update: Human Milk Oligosaccharide (HMO) Supplementation in Colic Management [NA]

View source ↗

Summary

Nestlé-sponsored trial evaluating human milk oligosaccharide supplementation for infant colic has been terminated. No results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Colic

Drugs mentioned

• Human Milk Oligosaccharide (HMO) supplement (Human milk oligosaccharide)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Colic | NA | Status: TERMINATED